Market closed · Next open: Monday 9:30 AM ET
Last update: Nov 6, 2026, 6:18 PM ET
Lam Research Corporation
$200.44▲ 8.23% today
Market Closed

Why Lam Research Corporation (LRCX) stock moved

Updated Nov 7, 2026

Lam Research Corporation (LRCX) shares climbed 8.2% to $200.44 as of November 7, 2026, a significant gain from the prior close of $185.20. BestStocks flagged the session as a material change for LRCX. Below, we break down what changed for LRCX, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

LRCX climbed 8.2% to $200.44

LRCX climbed 8.2% in its latest session, moving from $185.20 to $200.44.

ValuationSector-Wide MoveMedium confidence
Rel. volume
1.7×
Above Avg
Vs peers
Top 2 of 7 peers
Outperforming
Market cap
$250.8B
NASDAQ Global Select
Analyst target
$380
+89.8% vs price
Price chart
Oct 7 – Nov 6
VVVVVVVVV$185$257$330Oct 7Oct 15Oct 22Oct 30Nov 6
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for Lam Research Corporation investors

For Lam Research Corporation investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Strong 8.2% price move with conviction; Positive price momentum. Weighing against that: Lam Research reported record Q1 2027 revenue and achieved its first-ever 40% operating margin, but the stock fell 11.21% to $231.57 as investors reacted negatively to spending concerns raised during the earnings call, per Barron's; Lam Research declined 5.40% to $292.84 intraday with no identified company-specific catalyst in news or filings today. Because peers moved similarly, the shift looks more macro- or sector-driven than a change in LRCX's fundamentals. Wall Street's consensus price target sits at $380.41, implying +89.8% upside from $200.44. BestStocks rates the overall signal quality medium (67/100). With earnings roughly 81 days out, the next report is the most likely near-term test of the move.

LRCX price reaction

LRCX last traded at $200.44, up $15.24 (+8.23%) from the previous close of $185.20. The session traded on 1.7× average volume (above avg), so the move carried above-average conviction. Its technology peer group moved a median +5.5% over the same stretch, leaving LRCX ahead of the group by 2.7 points. Over the past month the stock has ranged between $185.20 and $329.51, and it currently sits about 11% of the way up that band.

Bullish and bearish analyst opinions on Lam Research Corporation (LRCX)

The consensus analyst price target on Lam Research Corporation (LRCX) is $380.41, 89.8% above the recent $200.44. Over the past 90 days analysts logged 0 upgrades, 10 maintains, and 0 downgrades. Here is how the bullish and bearish cases on LRCX line up.

The bullish case

  • Wall Street's consensus price target of $380.41 implies +89.8% upside from $200.44.
  • The Street's most bullish target is $500.00 (+149.5%).
  • Strong 8.2% price move with conviction.
  • Positive price momentum.
  • LRCX surged 8.60% to $411.68 on strong earnings results and topped targets as a chip-equipment maker.

The bearish case

  • Lam Research reported record Q1 2027 revenue and achieved its first-ever 40% operating margin, but the stock fell 11.21% to $231.57 as investors reacted negatively to spending concerns raised during the earnings call, per Barron's.
  • Lam Research declined 5.40% to $292.84 intraday with no identified company-specific catalyst in news or filings today.
Bull vs bear balanceNeutral / Mixed
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Nov 7, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $380+89.8%
= 10 maintains
UBS maintained Buy · 2026-10-22
SEC filings watch
8-K2026-11-05
Material event — review for impact
high
10-Q2026-10-22
Quarterly financial results
medium
8-K2026-10-21
Material event — review for impact
high
DEF 14A2026-09-24
Annual proxy — exec compensation & governance
low
Peer context
LRCX+8.2%
NVDA+2.8%
AMD+11.0%
INTC+7.7%
MU+5.1%
QCOM+5.5%

Previous notable changes for LRCX

Valuation2026-11-05-16.4%via Yahoo Finance ↗
Lam Research fell 11.66% to $195.62, driven by a confluence of sector-wide semiconductor and AI stock weakness amid rising Treasury yields, combined with company-specific concerns around slowing wafer fab equipment spending, China revenue headwinds from tighter U.S. export controls, and questions about whether memory-chip (NAND/DRAM) capex cycles will sustain into 2027, per web sources including finance.yahoo.com.
Valuation2026-10-30-6.0%via investing.com ↗
Lam Research shares fell 5.64% to $240.03 as analyst downgrades and sector-wide pressure in semiconductor equipment weighed on the stock. According to the web search synthesis, the decline is driven by an analyst downgrade combined with broader caution across semiconductor equipment and tech sectors, with market participants reassessing growth trajectories and valuations in AI-related hardware and memory. The move aligns with wider tech and chip-index pullbacks in early-session trading.
Valuation2026-10-28+5.4%via Yahoo Finance ↗
Lam Research rose 5.07% to $253.05, driven by semiconductor sector momentum and easing tariff uncertainty. According to Yahoo Finance, hedge funds have turned bullish on the stock amid clarity around tariff announcements that had weighed on the sector. Volume stands at 1.09x normal levels for this point in the session, indicating steady participation.
Risk2026-10-22-11.8%via 247wallst.com ↗
Lam Research reported record Q1 2027 revenue and achieved its first-ever 40% operating margin, but the stock fell 11.21% to $231.57 as investors reacted negatively to spending concerns raised during the earnings call, per Barron's. Volume surged to 2.52x the time-adjusted average, signaling heavy institutional selling despite the strong financial results.
Upcoming catalysts & outlook
Next earnings
2027-01-27 (est.)
in 81 days
Earnings Release
2027-01-27
High impact
10-K Annual Report (est.)
2027-08-07
Medium impact
Thesis shift
Neutral / Mixed
bullish signal
Risk level
High
from change events

Frequently asked questions about LRCX

Why did Lam Research Corporation (LRCX) stock move?

LRCX climbed 8.2% to $200.44. No single company-specific catalyst was confirmed during the move window, and it looks like a sector-wide move.

How much did LRCX stock rise?

LRCX gained 8.23% ($15.24) versus the prior close of $185.20, last trading at $200.44 on 1.7× average volume.

When is Lam Research Corporation's next earnings date?

LRCX's next earnings report is estimated for 2027-01-27 — about 81 days away.

What is the analyst price target for LRCX?

The consensus analyst price target for LRCX is $380.41, about 89.8% above the current $200.44. Over the past 90 days, analysts recorded 0 upgrades, 10 maintains, and 0 downgrades.

Is the LRCX move company-specific or sector-wide?

BestStocks classifies it as a sector-wide move: the peer group moved a median +5.5% against LRCX's +8.2%. LRCX ranks top 2 of 7 peers.

How BestStocks tracks LRCX

This page is generated automatically by BestStocks' change-detection system after its price and volume cleared LRCX-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for LRCX, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 7, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataAnalyst ratings & price targets (FMP)SEC EDGAR filingsEarnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.